Lipocalin 2 /NGAL

一个肾脏疾病和心血管疾病的标识物蛋白

MPLGLLWLGL ALLGALHAQA QDSTSDLIPA PPLSKVPLQQ NFQDNQFQGK WYVVGLAGNA

        70         80         90        100        110        120
ILREDKDPQK MYATIYELKE DKSYNVTSVL FRKKKCDYWI RTFVPGCQPG EFTLGNIKSY

       130        140        150        160        170        180
PGLTSYLVRV VSTNYNQHAM VFFKKVSQNR EYFKITLYGR TKELTSELKE NFIRFSKSLG

       190
LPENHIVFPV PIDQCIDG 198

1: Wu Y, Su T, Yang L, Zhu SN, Li XM. Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis. Am J Med Sci. 2010 Jun;339(6):537-42.

2: Shaker O, El-Shehaby A, El-Khatib M. Early Diagnostic Markers for Contrast Nephropathy in Patients Undergoing Coronary Angiography. Angiology. 2010 Jun 7. [Epub ahead of print].

3: Eagan TM, Damås JK, Ueland T, Voll-Aanerud M, Mollnes TE, Hardie JA, Bakke PS, Aukrust P. Neutrophil Gelatinase Associated Lipocalin - a biomarker in Chronic Obstructive Pulmonary Disease. Chest. 2010 May 21. [Epub ahead of print]

4: Allison SJ. Lupus nephritis: Urinary NGAL predicts renal flares in lupus nephritis. Nat Rev Nephrol. 2010 May;6(5):250.

5: Yang HN, Boo CS, Kim MG, Jo SK, Cho WY, Kim HK. Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in  acute kidney injury. Am J Nephrol. 2010;31(6):501-9. Epub 2010 May 4.